The bill also reauthorizes the FDA to collect user fees from prescription drug and medical device makers, and gives the agency authority to begin collecting user fees for generic drugs.
Next, the Senate will take up the bill and is expected to pass it on to President Obama who will likely sign it into law.
More Articles Related to the FDA:
Consumers Union Urges Congress to Strengthen Medical Device Safety
FDA Issues Draft Regulatory Guidance on New Breast Cancer Drug Trials Design
House Approves FDA Funding Bill to Reduce Drug Shortages
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
